Kyntra Bio (KYNB) Change in Inventory (2019 - 2026)
Kyntra Bio (KYNB) posted Change in Inventory of -$359000.0 for Q1 2026, down 194.26% sequentially from -$122000.0 in Q4 2025, and up 87.44% YoY from -$191524.7 in Q1 2025.
Kyntra Bio (KYNB) Change in Inventory (2019 - 2026) Analysis & Trends
Kyntra Bio has reported Change in Inventory for 8 years, with the latest figure at -$359000.0 in Q1 2026.
- Quarterly Change in Inventory rose 87.44% year-over-year to -$359000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.9 million (up 74.8% YoY) and the FY2025 annual result came in at -$5.4 million, up 75.94% from the prior year.
- Change in Inventory slipped to -$359000.0 in Q1 2026 per KYNB's latest filing, from -$122000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $12.0 million in Q1 2022 and troughed at -$13.8 million in Q1 2024.
- A 5-year average of -$900647.1 and a median of -$432000.0 in 2023 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2023 and 2024: Change in Inventory surged 218.92% in 2023, then slumped 16390.91% in 2024.
- Over 5 years, Change in Inventory stood at -$148000.0 in 2022, then soared by 218.92% to $176000.0 in 2023, then slumped by 2660.23% to -$4.5 million in 2024, then surged by 97.29% to -$122000.0 in 2025, then sank by 194.26% to -$359000.0 in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered -$359000.0, -$122000.0, and -$1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Kyntra Bio | 30.42 Mn | 30.42 Mn | 1.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -359,000.00 |
| Mar 31, 2026 | -359,000.00 |
| Dec 31, 2025 | -122,000.00 |
| Dec 31, 2025 | -122,000.00 |
| Sep 30, 2025 | -1.03 Mn |
| Sep 30, 2025 | -1.03 Mn |
| Jun 30, 2025 | -1.35 Mn |
| Jun 30, 2025 | -1.35 Mn |
| Mar 31, 2025 | -2.86 Mn |
| Mar 31, 2025 | -2.86 Mn |
| Dec 31, 2024 | -4.51 Mn |
| Dec 31, 2024 | -4.51 Mn |
| Sep 30, 2024 | -2.20 Mn |
| Sep 30, 2024 | -2.20 Mn |
| Jun 30, 2024 | -1.79 Mn |
| Jun 30, 2024 | -1.79 Mn |
| Mar 31, 2024 | -13.79 Mn |
| Mar 31, 2024 | -13.79 Mn |
| Dec 31, 2023 | 176,000.00 |
| Dec 31, 2023 | 176,000.00 |